World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
81
Citations
18139
World Ranking
3964
National Ranking
297

Philip S. Rudland publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Philip S. Rudland sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 326 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Philip S. Rudland D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Philip S. Rudland sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 81 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Philip S. Rudland is affiliated with the University of Liverpool in the United Kingdom. Their research focuses primarily on the fields of biochemistry, genetics, and molecular biology, as well as medicine. Within these broad areas, they have contributed extensively to subfields such as molecular biology, oncology, pulmonary and respiratory medicine, cancer research, and immunology and allergy.

The main research topics around which Philip S. Rudland's work centers include brain metastases and treatment, protease and inhibitor mechanisms, lung cancer research studies, ubiquitin and proteasome pathways, nuclear structure and function, cell adhesion molecules research, and peptidase inhibition and analysis.

Notable recent publications include:

  • Matrix metalloproteinase 2 is a target of the RAN-GTP pathway and mediates migration, invasion and metastasis in human breast cancer (2022, Life Sciences)
  • Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression (2022, ESMO Open)
  • Targeted Destruction of S100A4 Inhibits Metastasis of Triple Negative Breast Cancer Cells (2023, Biomolecules)
  • Genomic profiling using the UltraSEEK panel identifies discordancy between paired primary and breast cancer brain metastases and an association with brain metastasis-free survival (2021, Breast Cancer Research and Treatment)
  • Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer (2023, Life Sciences)

Philip S. Rudland frequently publishes in several key journals, including Life Sciences, Biomolecules, ESMO Open, Breast Cancer Research and Treatment, and Cancer Immunology Immunotherapy. Life Sciences is the most common venue with three publications.

Research collaborations often involve coauthors such as Angela Platt-Higgins, Mohamed El-Tanani, Rasheed Zakaria, Michael D. Jenkinson, and Shudong Zhang, with multiple joint publications recorded with these associates.

Best Publications

  • Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.

    Philip S. Rudland;Angela Platt-Higgins;Mohamed El-Tanani;Suzete de Silva Rudland

  • Distribution of Myoepithelial Cells and Basement Membrane Proteins in the Normal Breast and in Benign and Malignant Breast Diseases

    B A Gusterson;M J Warburton;D Mitchell;M Ellison

  • Prognostic Significance of the Metastasis-inducing Protein S100A4 (p9Ka) in Human Breast Cancer

    Philip S. Rudland;Angela Platt-Higgins;Christine Renshaw;Christopher R. West

  • Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1

    B. R. Davies;M. P. A. Davies;F. E. M. Gibbs;R. Barraclough

  • The long term prognostic significance of c-erbB-2 in primary breast cancer.

    J. Winstanley;T. Cooke;G. D. Murray;A. Platt-Higgins

  • Possible involvement of cyclic GMP in growth control of cultured mouse cells

    W. E. Seifert;P. S. Rudland;P. S. Rudland

  • Distribution of myoepithelial cells and basement membrane proteins in the resting, pregnant, lactating, and involuting rat mammary gland.

    M J Warburton;D Mitchell;E J Ormerod;P Rudland

  • A possible mammary stem cell line.

    Dorothy C. Bennett;Linda A. Peachey;Helga Durbin;Philip S. Rudland

  • Rat Muc4 (sialomucin complex) reduces binding of anti‐ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance

    Shari A. Price-Schiavi;Scott Jepson;Peter Li;Maria Arango

  • Initiation of cell proliferation in cultured mouse fibroblasts by prostaglandin F2alpha

    L J De Asua;D Clingan;P S Rudland

  • Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours.

    M. P. A. Davies;P. S. Rudland;L. Robertson;E. W. Parry

  • Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer.

    Michael P.A. Davies;Dong Liu Barraclough;Ceri Stewart;Kathryn A. Joyce

  • Human Homologue of Cement Gland Protein, a Novel Metastasis Inducer Associated with Breast Carcinomas

    Dong Liu;Philip S. Rudland;D. Ross Sibson;Angela Platt-Higgins

  • The regulation and role of osteopontin in malignant transformation and cancer

    Mohamed K. El-Tanani;Frederick Charles Campbell;Vittal Kurisetty;Dachuan Jin

  • THE IDENTIFICATION OF OSTEOPONTIN AS A METASTASIS-RELATED GENE PRODUCT IN A RODENT MAMMARY TUMOUR MODEL

    Oates Aj;Barraclough R;Rudland Ps

  • Induction of Metastasis by S100P in a Rat Mammary Model and Its Association with Poor Survival of Breast Cancer Patients

    Guozheng Wang;Angela Platt-Higgins;Joe Carroll;Suzete de Silva Rudland

  • Joining S100 proteins and migration: for better or for worse, in sickness and in health

    Stephane R. Gross;Connie Goh Then Sin;Roger Barraclough;Philip S. Rudland

  • Binding of Peanut Lectin to Breast Epithelium, Human Carcinomas, and a Cultured Rat Mammary Stem Cell: Use of the Lectin as a Marker of Mammary Differentiation

    Roland A. Newman;Peter J. Klein;Philip S. Rudland

  • Rat epidermal growth factor: complete amino acid sequence. Homology with the corresponding murine and human proteins; isolation of a form truncated at both ends with full in vitro biological activity.

    Richard J. Simpson;John A. Smith;Robert L. Moritz;Michael J. O'hare

  • Interaction of Heparan Sulfate from Mammary Cells with Acidic Fibroblast Growth Factor (FGF) and Basic FGF REGULATION OF THE ACTIVITY OF BASIC FGF BY HIGH AND LOW AFFINITY BINDING SITES IN HEPARAN SULFATE

    Hassan Rahmoune;Hai-Lan Chen;John T. Gallagher;Philip S. Rudland

Frequent Co-Authors

Roger Barraclough
Roger Barraclough University of Liverpool
David G. Fernig
David G. Fernig University of Liverpool
John A. Smith
John A. Smith University of Alabama at Birmingham
Christopher S. Foster
Christopher S. Foster University of Liverpool
Zihe Rao
Zihe Rao Tsinghua University
Patrick G. Johnston
Patrick G. Johnston Queen's University Belfast
Dorothy C. Bennett
Dorothy C. Bennett St George's, University of London
Malcolm Lyon
Malcolm Lyon University of Manchester
John T. Gallagher
John T. Gallagher University of Manchester
Kenneth J. O'Byrne
Kenneth J. O'Byrne Queensland University of Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens doors to various online degree options that can lead to rewarding careers in healthcare, research, and management. For those interested in direct patient care, asn online nursing programs offer a flexible way to start a nursing career with foundational science knowledge.

If you’re passionate about health, food, and the science behind nutrition, pursuing an online nutrition degree can lead to roles in health education, wellness coaching, and clinical nutrition support.

For those aiming for leadership in healthcare, cahme accredited online mha programs equip students with the skills needed for healthcare administration and management positions.

Advanced practice and research careers are also possible through online dnp programs, which focus on the highest level of nursing practice and leadership without requiring in-person clinicals.

Exploring these pathways can help you align your science background with meaningful and in-demand careers in today’s healthcare landscape.

Best Scientists Citing Philip S. Rudland

Trending Scientists

Recently Published Articles